Literature DB >> 2837487

Atrial natriuretic peptide clearance receptor. Complete sequence and functional expression of cDNA clones.

F Fuller1, J G Porter, A E Arfsten, J Miller, J W Schilling, R M Scarborough, J A Lewicki, D B Schenk.   

Abstract

The major class of atrial natriuretic peptide (ANP) receptors was isolated from cultured vascular smooth muscle cells, and a partial amino acid sequence was obtained. This allowed the isolation of cDNA clones from which the entire amino acid sequence was established. The smooth muscle cell ANP receptor appears to be synthesized as a 537-amino acid precursor with an N-terminal membrane translocation signal. The mature form consists of 496 amino acids with a single potential transmembrane domain predicting a 37-amino acid cytoplasmic domain and a large, acidic, extracellular domain low in cysteine and probably containing attached carbohydrate. The receptor is therefore similar in structure to the growth factor receptors but notably lacks repetitive cysteine-rich domains and has a relatively small intracellular domain. Expression of the cloned receptor in Xenopus oocytes elicited high affinity, membrane-associated binding sites for ANP and for truncated and internally deleted analogs of ANP. These results reflect the ligand binding specificity found for the major class of ANP receptors on smooth muscle cells and thus provide additional evidence that two distinct ANP receptors exist since ANP receptor-coupled guanylate cyclase activity exhibits a very different ANP analog specificity.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2837487

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  82 in total

1.  Inhibition of atrial natriuretic peptide (ANP) C receptor expression by antisense oligodeoxynucleotides in A10 vascular smooth-muscle cells is associated with attenuation of ANP-C-receptor-mediated inhibition of adenylyl cyclase.

Authors:  A Palaparti; Y Li; M B Anand-Srivastava
Journal:  Biochem J       Date:  2000-03-01       Impact factor: 3.857

Review 2.  The Venus flytrap of periplasmic binding proteins: an ancient protein module present in multiple drug receptors.

Authors:  C B Felder; R C Graul; A Y Lee; H P Merkle; W Sadee
Journal:  AAPS PharmSci       Date:  1999

Review 3.  Receptor guanylyl cyclases.

Authors:  S K Wong; D L Garbers
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

4.  Conservation of the kinaselike regulatory domain is essential for activation of the natriuretic peptide receptor guanylyl cyclases.

Authors:  K J Koller; F J de Sauvage; D G Lowe; D V Goeddel
Journal:  Mol Cell Biol       Date:  1992-06       Impact factor: 4.272

5.  Kinetic analysis of internalization, recycling and redistribution of atrial natriuretic factor-receptor complex in cultured vascular smooth-muscle cells. Ligand-dependent receptor down-regulation.

Authors:  K N Pandey
Journal:  Biochem J       Date:  1992-11-15       Impact factor: 3.857

Review 6.  Use of Xenopus oocytes for the functional expression of plasma membrane proteins.

Authors:  E Sigel
Journal:  J Membr Biol       Date:  1990-09       Impact factor: 1.843

Review 7.  Regulation and therapeutic targeting of peptide-activated receptor guanylyl cyclases.

Authors:  Lincoln R Potter
Journal:  Pharmacol Ther       Date:  2010-12-24       Impact factor: 12.310

8.  Differential regional expression of three natriuretic peptide receptor genes within primate tissues.

Authors:  J N Wilcox; A Augustine; D V Goeddel; D G Lowe
Journal:  Mol Cell Biol       Date:  1991-07       Impact factor: 4.272

9.  Atrial natriuretic peptide inhibits the phosphoinositide hydrolysis in murine Leydig tumor cells.

Authors:  M L Khurana; K N Pandey
Journal:  Mol Cell Biochem       Date:  1996-05-24       Impact factor: 3.396

10.  Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide.

Authors:  M Mukoyama; K Nakao; K Hosoda; S Suga; Y Saito; Y Ogawa; G Shirakami; M Jougasaki; K Obata; H Yasue
Journal:  J Clin Invest       Date:  1991-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.